DRUG COMBINATIONS FOR CEREBROVASCULAR DISEASE

摘要

The invention provides a drug combination of at least two compounds selected from the group consisting of Valproate, Ketamine, Tacrolimus, Clevidipine and Joro Spider Toxin that can be administered parenterally or orally to patients over 18 years of age at the onset of stroke symptoms or Transient Ischemic Attack (TIA). The drug combination may be administered regardless of stroke etiology (ischemic vs. hemorrhagic); may be given up to 6 hours following the onset of stroke and should not interfere with the subsequent action of thrombolytic agents such as tPA (Tissue Plasminogen Activator).